Please login to the form below
PMBCL
This page shows the latest PMBCL news and features for those working in and with pharma, biotech and healthcare.
NHS chief pledges CAR-T support, but asks for pricing restraint
primary mediastinal B-cell lymphoma (PMBCL) and transformed follicular lymphoma (TFL).
Latest news
-
Novartis files CAR-T therapy CTL109 in Europe
Kite was the first to file its new therapy in Europe, seeking approval in August for DLBCL, transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) in adults ineligible
-
Kite starts EU trial of lead CAR-T therapy
Adult patients with DLBCL, PMBCL and TFL will be enrolled in the trial. ... Kite is currently enrolling adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), and transformed follicular
-
Kite files first CAR-T candidate in Europe
cell lymphoma (PMBCL) who are ineligible for autologous stem cell transplant.
-
Kite Pharma soars after positive CAR-T data in lymphoma
B-cell lymphoma (PMBCL) - on the strength of the trial results.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
